Zacks Investment Research
13 May 2026, 23:41 UTC · 19w ago
Verdict
Headline leans bearish. We score MBOT +0.20 across four claims.
Score contradicts the headline.
Leans bearish
From its wording — no explicit rating
+0.20slightly bullish
What the story claims
4 claims · scored −1 bearish … +1 bullish
Microbot Medical missed revenue estimates by 76.67%, reporting just $0.11 million against consensus for the quarter ended March 2026.
So whatA massive top-line miss drastically outweighs the EPS beat for a pre-revenue stage medical device company, signaling weak commercialization progress.
More negative than 98% of claims this week
Microbot Medical reported a quarterly loss of $0.05 per share, beating the Zacks Consensus Estimate of a $0.08 loss by 37.50%.
So whatA significant EPS surprise is positive, but bottom-line beats matter less for early-stage companies than revenue generation.
Continue reading
5 related stories
More positive than 54% of ticker scores this week
Scored by the NIS engine · methodology.
Top 3 movers · tap to explore
More positive than 78% of claims this week
Microbot Medical currently holds a Zacks Rank #2 (Buy) due to favorable earnings estimate revisions ahead of the release.
More positive than 65% of claims this week
Microbot Medical shares have gained 9.5% year-to-date, outperforming the S&P 500's 8.1% gain.
More positive than 44% of claims this week
Which stocks this story touches
More positive than 54% of ticker scores this week
The company beat earnings expectations with a smaller-than-expected loss and has a Zacks Rank #2 (Buy), despite missing revenue estimates.
More positive than 48% of ticker scores this week
Significant growth in page views suggests increasing investor attention.
More positive than 48% of ticker scores this week
Mentioned as a top-trending stock by page views, indicating high investor interest.
More positive than 48% of ticker scores this week
Mentioned as a top-trending stock by page views, indicating high investor interest.
More positive than 48% of ticker scores this week
Mentioned as a top-trending stock by page views, indicating high investor interest.
More positive than 48% of ticker scores this week
Mentioned as a top-trending stock by page views, indicating high investor interest.
More positive than 48% of ticker scores this week
Significant growth in page views suggests increasing investor attention.
More positive than 48% of ticker scores this week
Significant growth in page views suggests increasing investor attention.
More positive than 48% of ticker scores this week
Significant growth in page views suggests increasing investor attention.
More positive than 48% of ticker scores this week
Significant growth in page views suggests increasing investor attention.
More positive than 48% of ticker scores this week
Mentioned as a top-trending stock by page views, indicating high investor interest.
More positive than 48% of ticker scores this week
Mentioned as a top-trending stock by page views, indicating high investor interest.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
−41.2%
Price is moving against the score
$1.27 vs $2.17 close before publication (May 13) · not market-adjusted
MBOT chart →